6.5 C
New York
Sunday, September 25, 2022

Aspirin, a simple and efficient remedy to prevent COVID-19?

Must Read

New Study Explains Why Women Self-selecting Out Of STEM – It’s Not About Being “White Or Male” Anymore

Even though women and people of color have made small gains in STEM (Science, Technology, Engineering and Mathematics)...

Live Liver Donor Transplants Can Save More Lives In The US

A new study in the Journal of Hepatology says that liver transplants from living donors can cut...

Soldiers Who Refuse To Go To War May Face A Jail Term Up To 10 Years – Russia’s New Criminal Code

According to the official legal information portal, President Vladimir Putin has approved changes to the law to...
Avatar photo
Aakash Molpariya
Aakash started in Nov 2018 as a writer at Revyuh.com. Since joining, as writer, he is mainly responsible for Software, Science, programming, system administration and the Technology ecosystem, but due to his versatility he is used for everything possible. He writes about topics ranging from AI to hardware to games, stands in front of and behind the camera, creates creative product images and much more. He is a trained IT systems engineer and has studied computer science. By the way, he is enthusiastic about his own small projects in game development, hardware-handicraft, digital art, gaming and music. Email: aakash (at) revyuh (dot) com

Israeli scientists discovered that aspirin, a cheap and safe drug, reduces the likelihood of contracting COVID-19. And it also affects both the duration and severity of the disease, and even mortality.

Aspirin, a common medication often prescribed to prevent and treat cardiovascular disease and as a pain reliever and fever reducer, is known to help the human immune system fight certain viral infections. It was used extensively during the 1918 ‘Spanish flu’ pandemic, and scientists subsequently confirmed its activity against RNA viruses in vitro.

Researchers from the Israeli medical organization Leumit Health Services, Bar Ilán University, and Barzilai Medical Center hypothesized that preventive administration of low-dose aspirin – about 75 milligrams a day – could reduce susceptibility to the coronavirus and alleviate the COVID-19 disease in case of infection.

The authors of the study, published in The FEBS Journal, analyzed the PCR test results of 10,477 people during the first wave of COVID-19 in Israel from February 1 to June 30, 2020. A separate group of people was formed generally healthy who took aspirin to prevent cardiovascular disease.

It turned out that the use of aspirin reduced the probability of contracting the coronavirus by 29%, and the duration of illness in those who took aspirin was 2 to 3 days shorter. Among those hospitalized for coronavirus, the death rate was also lower in the group of people taking aspirin: 14% compared to 19% in the control group.

At the same time, the scientists note that “the potential beneficial effect of low-dose aspirin on COVID-19 infection is preliminary but looks very promising,” according to Professor Eli Magen from Barzilai Medical Center, lead author of the study.

The authors insist on the need for more studies with larger randomized clinical samples and the inclusion of patients from other hospitals and countries to verify the results obtained, and also warn of the danger of taking the drug without consulting the doctor first.

- Advertisement -
- Advertisement -

Latest News

- Advertisement -

More Articles Like This

- Advertisement -